Changing Frontline AML Treatment Patterns in Alberta, Canada from 2013 - 2022
Ebeling, Kurt, Wang, Peng, Liew, Elena, Zhu, Nancy, Hnatiuk, Mark, Taparia, Minakshi S., Hamilton, Marlene, Brandwein, Joseph
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Changing frontline AML treatment patterns from 2013 to 2022
Brandwein, Joseph M., Ebeling, Kurt, Ding, Lei, Liew, Elena, Zhu, Nancy, Bolster, Lauren, Hamilton, Marlene, Hnatiuk, Mark, Wang, Peng
Published in Leukemia research (01.09.2023)
Published in Leukemia research (01.09.2023)
Get full text
Journal Article
Risk Factor Analysis for Second Treatment-Free Remission Failure from the Canadian TKI Discontinuation (TRAD) Trial in CML Patients: Treatment-Free Remission Accomplished By Dasatinib
Perusini, Maria Agustina, Atenafu, Eshetu G., Forrest, Donna L., Isabelle, Bence-Bruckler, Savoie, Lynn, Keating, Mary-Margaret, Busque, Lambert, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Laneuville, Pierre, Paulson, Kristjan, Stockley, Tracy L., Lipton, Jeffrey H., Leber, Brian, Kim, Dennis Dong Hwan
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD) study
Perusini, Maria Agustina, Novitzky‐Basso, Igor, Atenafu, Eshetu G., Forrest, Donna, Bence‐Bruckler, Isabelle, Savoie, Lynn, Keating, Mary‐Margaret, Busque, Lambert, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Laneuville, Pierre, Paulson, Kristjan, Stockley, Tracy, Lipton, Jeffrey H., Leber, Brian, Kim, Dennis Dong Hwan
Published in British journal of haematology (01.12.2023)
Published in British journal of haematology (01.12.2023)
Get full text
Journal Article
Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI
Ma, Chen-En, Ghosh, Sunita, Leyshon, Catherine, Blosser, Nikki, Dersch-Mills, Deonne, Jupp, Jennifer, Savoie, Lynn, Liew, Elena, Jamani, Kareem
Published in Leukemia research (01.12.2021)
Published in Leukemia research (01.12.2021)
Get full text
Journal Article
A phase II study of cpi-0610, a bromodomain and extraterminal protein inhibitor (BETi) alone or with ruxolitinib (RUX), in patients with myelofibrosis (MF)
Kremyanskaya, Marina, Hoffman, Ronald, Mascarenhas, John, Bose, Prithviraj, Gupta, Vikas, Schiller, Gary J., Liew, Elena, Lebedinsky, Claudia, Senderowicz, Adrian Mario, Mertz, Jennifer, Trojer, Patrick, Verstovsek, Srdan
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial
Kim, Dennis D. H., Novitzky‐Basso, Igor, Kim, Taehyung S., Atenafu, Eshetu G., Forrest, Donna, Savoie, Lynn, Bence‐Bruckler, Isabelle, Keating, Mary‐Margaret, Busque, Lambert, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Paulson, Kristjan, Stockley, Tracy, Laneuville, Pierre, Lipton, Jeffrey H., Kamel‐Reid, Suzanne, Leber, Brian
Published in British journal of haematology (01.05.2021)
Published in British journal of haematology (01.05.2021)
Get full text
Journal Article
The Canadian Tyrosine Kinase Inhibitor Discontinuation Trial with Imatinib Discontinuation As a First Attempt and with Dasatinib Discontinuation As a Second Attempt of Treatment-Free Remission: Results of 4 Years of Follow-up
Kim, Dennis Dong Hwan, Bence-Bruckler, Isabelle, Busque, Lambert, Forrest, Donna L., Savoie, Lynn, Keating, Mary-Margaret, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Laneuville, Pierre, Paulson, Kristjan, Lipton, Jeffrey H., Kamel-Reid, Suzanne, Leber, Brian
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Comprehensive Analysis of Hematological Parameter Changes after TKI Discontinuation for Treatment-Free Remission Attempt
Daher-Reyes, Georgina S., Bence-Bruckler, Isabelle, Busque, Lambert, Forrest, Donna L., Savoie, Lynn, Keating, Mary-Margaret, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Laneuville, Pierre, Paulson, Kristjan, Lipton, Jeffrey H., Kamel-Reid, Suzanne, Leber, Brian, Kim, Dennis Dong Hwan
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
BCR-ABL1 qPCR-Based Doubling Time within the First 6 Months after Imatinib Discontinuation Is a Predictive of Successful TKI Treatment-Free Remission
Daher-Reyes, Georgina S., Bence-Bruckler, Isabelle, Busque, Lambert, Forrest, Donna L., Savoie, Lynn, Keating, Mary-Margaret, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Laneuville, Pierre, Paulson, Kristjan, Lipton, Jeffrey H., Kamel-Reid, Suzanne, Leber, Brian, Kim, Dennis Dong Hwan
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
An evaluation of no‐treatment decisions in patients with newly diagnosed acute myeloid leukemia
Brandwein, Joseph M., Hallett, Darren, Karkhaneh, Mohammad, Zhu, Nancy, Liew, Elena, Bolster, Lauren, Hamilton, Marlene, Patterson, Jeffrey, Taparia, Minakshi, Wu, Cynthia, Van Slyke, Tiffany, Bankar, Aniket, Saini, Lalit
Published in American journal of hematology (01.01.2021)
Published in American journal of hematology (01.01.2021)
Get full text
Journal Article
BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase
Kim, Dennis Dong Hwan, Kim, Taehyung Simon, Atenafu, Eshetu G., Novitzky Basso, Igor, Forrest, Donna, Bence‐Bruckler, Isabelle, Savoie, Lynn, Busque, Lambert, Keating, Mary‐Margaret, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Paulson, Kristjan, Stockley, Tracy, Laneuville, Pierre, Lipton, Jeffrey H., Kamel‐Reid, Suzanne, Leber, Brian
Published in British journal of haematology (01.01.2022)
Published in British journal of haematology (01.01.2022)
Get full text
Journal Article
BCR-ABL1 Transcript Doubling Time after Imatinib Discontinuation for Treatment-Free Remission in Chronic Myeloid Leukemia in Chronic Phase: Predictor for Treatment-Free Remission Failure
Kim, Dennis Dong Hwan, Novitzky-Basso, Igor Nicolas, Kim, Taehyung, Atenafu, Eshetu G, Forrest, Donna L., Savoie, Lynn, Bence-Bruckler, Isabelle, Keating, Mary-Margaret, Busque, Lambert, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Paulson, Kristjan, Stockley, Tracy L., Laneuville, Pierre, Lipton, Jeffrey H., Kamel-Reid, Suzanne, Leber, Brian
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Optimal Duration of Imatinib Treatment / Deep Molecular Response for Treatment-Free Remission after Imatinib Discontinuation from a Canadian Tyrosine Kinase Inhibitor Discontinuation Trial
Kim, Dennis Dong Hwan, Novitzky-Basso, Igor Nicolas, Kim, Taehyung, Atenafu, Eshetu G, Savoie, Lynn, Bence-Bruckler, Isabelle, Forrest, Donna L., Busque, Lambert, Delage, Robert, Xenocostas, Anargyros, Keating, Mary-Margaret, Liew, Elena, Paulson, Kristjan, Stockley, Tracy L., Laneuville, Pierre, Lipton, Jeffrey H., Kamel-Reid, Suzanne, Leber, Brian
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Second Attempt of TKI Discontinuation with Dasatinib for Treatment-Free Remission after Failing First Attempt with Imatinib: Treatment-Free Remission Accomplished By Dasatinib (TRAD) Trial
Kim, Dennis Dong Hwan, Busque, Lambert, Forrest, Donna L., Savoie, Lynn, Bence-Bruckler, Isabelle, Couban, Stephen, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Laneuville, Pierre, Paulson, Kristjan, Lipton, Jeffrey H., Kamel-Reid, Suzanne, Leber, Brian
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Interim Results of the Canadian Tyrosine Kinase Inhibitor Discontinuation Trial for 2nd Attempt of Treatment Free Remission: Treatment Free Remission Accomplished By Dasatinib (TRAD)
Kim, Dennis, Bence-Bruckler, Isabelle, Forrest, Donna L, Savoie, Lynn, Couban, Stephen, Busque, Lambert, Delage, Robert, Laneuville, Pierre, Liew, Elena, Xenocostas, Anargyros, Paulson, Kristjan, Kamel-Reid, Suzanne, Lipton, Jeffrey H., Leber, Brian
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Treatment-Free Remission Accomplished By Dasatinib (TRAD): Preliminary Results of the Pan-Canadian Tyrosine Kinase Inhibitor Discontinuation Trial
Kim, Dennis Dong Hwan, Bence-Bruckler, Isabelle, Forrest, Donna L., Savoie, Mary Lynn, Couban, Stephen, Busque, Lambert, Delage, Robert, Laneuville, Pierre, Liew, Elena, Xenocostas, Anargyros, Paulson, Kristjan, Kamel-Reid, Suzanne, Lipton, Jeff H., Leber, Brian
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article